News Daily News AF Common, Worsens Prognosis After Stem Cell Transplant for Multiple Myeloma This reinforces the need for a CV assessment and surveillance before, during, and after the therapy, a researcher says. Todd Neale February 24, 2026
Presentation THT Abstracts 2026 Real-World Association of SGLT2 Inhibitors With Survival and Arrhythmic Risk in Advanced Cardio-Renal Disease Presenter: Mazen Ahmed March 02, 2026
Presentation THT Abstracts 2026 Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction Presenter: Nishanth Katukuri March 02, 2026
Presentation THT Abstracts 2026 Rising Mortality from Concurrent Heart Failure and Ventricular Tachycardia: A 25-Year Trend Analysis Presenter: Hriday Shah March 02, 2026
Presentation ESC 2025 ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation Presenter: Jonas Oldgren August 30, 2025
Presentation ESC 2025 POTCAST: A Randomized Controlled Trial Showing Arrhythmia Prevention Using Targeted Plasma Potassium Levels in ICD Patients Presenter: Henning Bundgaard August 29, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2026 By Michael O'Riordan March 02, 2026
News Daily News AF Common, Worsens Prognosis After Stem Cell Transplant for Multiple Myeloma By Todd Neale February 24, 2026
News Opinion CV Team Dispatch February 2026 Dispatch for the CV Team By L.A. McKeown February 18, 2026
News Daily News Q&A: Lior Jankelson on AI Tools for Suspected ACS and More By Todd Neale February 10, 2026
News Daily News PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF By Todd Neale January 27, 2026